Association of Primary Open-Angle Glaucoma with Tinnitus: A Nationwide Population-Based Study
Document Type
Article
Abstract
PRCIS: This study aims to investigate the association between primary open-angle glaucoma (POAG) and tinnitus. We found that tinnitus was significantly associated with preexisting POAG [adjusted odds ratio (OR)=1.298]. PURPOSE: The purpose of this study was to investigate the association between POAG and tinnitus using nationwide population-based data from Taiwan. METHODS: Data for this case-control study were retrieved from the Taiwan National Health Insurance Research Database for all 542,682 patients with a first-time diagnosis of tinnitus (cases), and 1,628,046 propensity score-matched controls from Taiwan's National Health Insurance system. We performed multiple logistic regression analysis to estimate the odds (ORs) of prior POAG among cases versus controls. RESULTS: Of total 2,170,728 study patients, 85,257 (3.93%) had POAG before the index date of tinnitus, 25,496 (4.70%) among cases and 59,761 (3.67%) among controls (P<0.001). Multiple logistic regression analysis showed a significant association between prior POAG and tinnitus (OR=1.298, 95% confidence interval: 1.278-1.318) after adjusting for age, sex, monthly income, geographic location and residential urbanization level, hyperlipidemia, diabetes, obesity, anemia, rheumatoid arthritis, alcohol abuse, nicotine dependence, anxiety disorder, depressive disorder, and hypertension. CONCLUSIONS: Patients with POAG have a higher risk of tinnitus compared with those without the disease. Ophthalmologists should be aware of this association and further studies are needed to understand underlying mechanisms.
Digital Object Identifier (DOI)
Publication Info
Published in Journal of Glaucoma, Volume 31, Issue 4, 2022, pages 224-227.
APA Citation
Kuang, T.-M., Sudha Xirasagar, Cheng, Y.-F., Kuo, N.-W., & Lin, H.-C. (2022). Association of Primary Open-angle Glaucoma With Tinnitus: A Nationwide Population-Based Study. Journal of Glaucoma, 31(4), 224–227.https://doi.org/10.1097/IJG.0000000000002001
Rights
© 2022 Wolters Kluwer Health, Inc. All rights reserved.